Mapi – Pharma Ltd.

General Information
We are a clinical stage pharmaceutical company, engaged in the development of improved extended-release versions of existing commercially successful products, which we refer to as LCM products, that target large markets as well as high-barrier to entry and high-added value generic drugs.
Employees: 23
Founded: 2008
Contact Information
Address Weizmann Science Park, 16 Einstein St. P.O. Box 4113, Ness Ziona, Israel 74140
Phone Number +972 (73) 712-1213.
Web Address
View Prospectus: Mapi – Pharma Ltd.
Financial Information
Market Cap $188.5mil
Revenues $0.6 mil (last 12 months)
Net Income $-6.7 mil (last 12 months)
IPO Profile
Symbol MAPI
Exchange NASDAQ
Shares (millions): 3.1
Price range $15.00 - $17.00
Est. $ Volume $50.0 mil
Manager / Joint Managers JMP Securities
CO-Managers FBR/ Maxim Group
Expected To Trade:
Status: Withdrawn
Quiet Period Expiration Date:
Lock-Up Period Expiration Date:
SCOOP Rating
Rating Change